We are live on ! Find out more
AEPBI

AH Equity Partners Bio II Portfolio holdings

AUM $144M
1-Year Est. Return 54.61%
This Fund
S&P 500
This Quarter Est. Return
+3.69%
1 Year Est. Return
-54.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
+$1.1M
Cap. Flow
+$323K
Cap. Flow %
0.23%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
NVTA
Invitae Corporation
NVTA
+$323K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 97.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EQRX
1
DELISTED
EQRx, Inc. Common Stock
EQRX
$86.3M 60.15%
17,438,465
– –
NAUT icon
2
Nautilus Biotechnolgy
NAUT
$215M
$34.6M 24.08%
16,298,006
– –
ERAS icon
3
Erasca
ERAS
$6.53B
$19.5M 13.59%
2,500,000
– –
NVTA
4
DELISTED
Invitae Corporation
NVTA
$3.14M 2.19%
1,276,541
+106,414
+9% +$323K

Similar funds

JAMH
Junson Asset Management (HK) Hong Kong $147M AUM 33.59% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
MPU
MVM Partners (UK) London, United Kingdom $149M AUM 6.81% 1-Year Est. Return
HGM
Highside Global Management Dallas, Texas $136M AUM 36.73% 1-Year Est. Return
EVC
Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return
SP
StackLine Partners New York $134M AUM 35.15% 1-Year Est. Return
SC
Siena Capital Cincinnati, Ohio $153M AUM 9% 1-Year Est. Return
SCM
Salem Capital Management Woburn, Massachusetts $126M AUM 8.82% 1-Year Est. Return

AH Equity Partners Bio II's Q3 2022 Portfolio in Review

As of Q3 2022, AH Equity Partners Bio II held 4 positions worth $144M, up 0.78% from $142M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. AH Equity Partners Bio II opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 98% a quarter earlier.

  • AH Equity Partners Bio II added most to Invitae Corporation in Q3 2022, an estimated $323K increase.
  • AH Equity Partners Bio II's ten largest holdings make up 100% of its $144M portfolio in Q3 2022.
  • AH Equity Partners Bio II opened 0 new positions and closed 0 in Q3 2022.
  • AH Equity Partners Bio II's portfolio value rose 0.78% quarter-over-quarter to $144M.

Based on AH Equity Partners Bio II's 13F filing for Q3 2022, filed 14 Nov 2022.